Before Rolfe Foundation was founded 20 years ago, there were only a handful of researchers in the country devoted to fighting pancreatic cancer. Today, there are thousands of committed experts invested in this cause, and we owe this progress to the unwavering support of our dedicated community.

Highlighted are a few of the groundbreaking projects we will continue to support, with your help:

** CancerSEEK -- Funding the next phase for CancerSEEK, led by Dr. Bert Vogelstein, will further advance and commercialize the liquid biopsy test designed to detect pancreatic cancer at an earlier stage. (Johns Hopkins)

** Epigenetic Patterns -- By studying epigenetic patterns on DNA, Dr. Chuan He can begin to develop blood tests to monitor patients who are at risk for pancreatic cancer. If diagnosed, the epigenetic test would provide physicians with valuable prognostic information to select the best therapies for patients. (University of Chicago)

** Pancreatic Cancer Biomarkers -- Dr. Ralph Hruban and his team are developing a method to culture precancer lesions in three-dimensions, providing a critical system to study pancreatic precancers. Identifying precursor lesions before they become incurable invasive cancer is a key to early detection. (Johns Hopkins)

Early detection means the difference between life and death with pancreatic cancer. Every dollar matters in the fight against this deadly disease.

We hope we can count on you. If 2,000 people donate just $50 each, we will exceed our goal and make a huge difference!

Thank you for your support.